{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:21:57Z","timestamp":1791264117404,"version":"4.1.0"},"reference-count":81,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Atypical antipsychotic agents are a frequently and effectively used treatment in schizophrenia and psychotic disorders. Other than conventional antipsychotics, which mainly exert their pharmacological effect in subcortical dopaminergic systems, atypical antipsychotics additionally affect partly serotonergically innervated structures within prefrontal areas, such as the anterior cingulate cortex (ACC). However, only few controlled, randomized studies have so far investigated direct and indirect effects of atypical antipsychotics on the ACC and, up until now, no clinical investigation has exclusively addressed the specific effects of quetiapine on ACC function. The present study assessed ACC function in 18 quetiapine-medicated patients and 13 flupentixol-treated patients suffering from schizophrenia by means of the error-related negativity (ERN), a neurophysiological marker of ACC function, in a pre-post design. Between-group comparisons revealed different effects of quetiapine and flupentixol on ACC function despite similar improvement in psychopathology, cognitive performance and quality of life. Whereas atypical treatment was associated with an increase in amplitudes over time, there were prolonged ERN peak latencies in patients treated with the typical agent. Moreover, treatment effects depended on baseline prefrontal cortex function in both groups. We conclude that both flupentixol and quetiapine improve prefrontal function especially in patients with weak initial ACC function which might be due to their shared affinity for serotonin receptors in frontal brain regions. However, since this affinity is more pronounced for quetiapine, patients treated with quetiapine seemed to profit more evidently concerning their prefrontal cortex function compared to patients of the flupentixol group, who exhibited a compensatory prolongation of processes.<\/jats:p>","DOI":"10.1017\/s1461145713000540","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T08:30:52Z","timestamp":1371025852000},"page":"1911-1925","source":"Crossref","is-referenced-by-count":11,"title":["Quetiapine and flupentixol differentially improve anterior cingulate cortex function in schizophrenia patients: an event-related potential study"],"prefix":"10.1093","volume":"16","author":[{"given":"Sabrina","family":"Schneider","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Juergen","family":"Bahmer","sequence":"additional","affiliation":[{"name":"Medical Department, University of Tuebingen, Germany"},{"name":"Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian Gerhard","family":"Metzger","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Germany"},{"name":"Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Reif","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Polak","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pfuhlmann","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Walter","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark-Christian","family":"Eberle","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena Helene","family":"Ernst","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Germany"},{"name":"Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas Jochen","family":"Fallgatter","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Germany"},{"name":"Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Christine","family":"Ehlis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Tuebingen, Germany"},{"name":"Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,10,1]]},"reference":[{"key":"2019101113493814100_ref1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.eurpsy.2004.11.003","article-title":"Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies","volume":"20","author":"Abi-Dargham","year":"2005","journal-title":"Eur Psychiatry"},{"key":"2019101113493814100_ref2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/cercor\/12.8.840","article-title":"Neurophysiological evidence of error-monitoring deficits in patients with schizophrenia","volume":"12","author":"Alain","year":"2002","journal-title":"Cereb Cortex"},{"key":"2019101113493814100_ref3","volume-title":"Psychotropic drug directory 2005","author":"Bazire","year":"2005"},{"key":"2019101113493814100_ref4","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.neuroimage.2010.09.046","article-title":"Error processing network dynamics in schizophrenia","volume":"54","author":"Becerril","year":"2011","journal-title":"Neuroimage"},{"key":"2019101113493814100_ref5","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1037\/0033-295X.108.3.624","article-title":"Conflict monitoring and cognitive control","volume":"108","author":"Botvinick","year":"2001","journal-title":"Psychol Rev"},{"key":"2019101113493814100_ref6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.tics.2004.10.003","article-title":"Conflict monitoring and anterior cingulate cortex: an update","volume":"8","author":"Botvinick","year":"2004","journal-title":"Trends Cogn Sci"},{"key":"2019101113493814100_ref7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00213-004-1915-6","article-title":"Drug-induced stimulation and suppression of action monitoring in healthy volunteers","volume":"177","author":"Bruijn","year":"2004","journal-title":"Psychopharmacology"},{"key":"2019101113493814100_ref8","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1176\/appi.ajp.158.9.1423","article-title":"Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study","volume":"158","author":"Carter","year":"2001","journal-title":"Am J Psychiatry"},{"key":"2019101113493814100_ref9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-3-642-25758-2_4","article-title":"Towards medication-enhancement of cognitive interventions in schizophrenia","volume-title":"Novel antischizophrenia treatments","author":"Chou","year":"2012"},{"key":"2019101113493814100_ref10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/archpsyc.60.6.553","article-title":"A meta-analysis of the efficacy of second-generation antipsychotics","volume":"60","author":"Davis","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"2019101113493814100_ref11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/brain\/118.1.279","article-title":"Review Article: contributions of anterior cingulate cortex to behaviour","volume":"118","author":"Devinsky","year":"1995","journal-title":"Brain"},{"key":"2019101113493814100_ref12","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00406-005-0562-1","article-title":"Beneficial effect of atypical antipsychotics on prefrontal brain function in acute psychotic disorders","volume":"255","author":"Ehlis","year":"2005","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2019101113493814100_ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pscychresns.2006.11.007","article-title":"Cortical activation during two verbal fluency tasks in schizophrenic patients and healthy controls as assessed by multi-channel near-infrared spectroscopy","volume":"156","author":"Ehlis","year":"2007","journal-title":"Psychiatry Res: Neuroimaging"},{"key":"2019101113493814100_ref14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajmg.b.31161","article-title":"Influence of a genetic variant of the neuronal growth associated protein Stathmin 1 on cognitive and affective control processes: an event-related potential study","volume":"156B","author":"Ehlis","year":"2011","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"2019101113493814100_ref15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3109\/15622975.2011.566354","article-title":"Hypofrontality in schizophrenic patients and its relevance for the choice of antipsychotic medication: an event-related potential study","volume":"13","author":"Ehlis","year":"2012","journal-title":"World J Biol Psychiatry"},{"key":"2019101113493814100_ref16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1017\/S003329170001240X","article-title":"Experiences of alien control in schizophrenia reflect a disorder in the central monitoring of action","volume":"19","author":"Firth","year":"1989","journal-title":"Psychol Med"},{"key":"2019101113493814100_ref17","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/schbul\/sbn025","article-title":"Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology","volume":"35","author":"Fornito","year":"2009","journal-title":"Schizophr Bull"},{"key":"2019101113493814100_ref18","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1467-9280.1993.tb00586.x","article-title":"A neural system for error detection and compensation","volume":"4","author":"Gehring","year":"1993","journal-title":"Psychol Sci"},{"key":"2019101113493814100_ref19","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/archpsyc.64.10.1115","article-title":"Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?","volume":"64","author":"Goldberg","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"2019101113493814100_ref20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/0013-4694(83)90135-9","article-title":"A new method for off-line removal of ocular artifact","volume":"55","author":"Gratton","year":"1983","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"2019101113493814100_ref21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1176\/ajp.153.3.321","article-title":"What are the functional consequences of neurocognitive deficits in schizophrenia?","volume":"153","author":"Green","year":"1996","journal-title":"Am J Psychiatry"},{"key":"2019101113493814100_ref22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.schres.2004.09.009","article-title":"Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS","volume":"72","author":"Green","year":"2004","journal-title":"Schizophr Res"},{"key":"2019101113493814100_ref23","first-page":"20","article-title":"Cognitive outcomes in the CATIE schizophrenia trial \u2013 Why do they seem different from previous results?","volume":"4","author":"Harvey","year":"2007","journal-title":"Psychiatry"},{"key":"2019101113493814100_ref24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3109\/15622975.2012.739708","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects","volume":"14","author":"Hasan","year":"2013","journal-title":"World J Biol Psychiatry"},{"key":"2019101113493814100_ref25","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1037\/0894-4105.12.3.426","article-title":"Neurocognitive deficit in schizophrenia: a quantitative review of the evidence","volume":"12","author":"Heinrichs","year":"1998","journal-title":"Neuropsychology"},{"key":"2019101113493814100_ref26","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cogbrainres.2004.02.013","article-title":"Source localization (LORETA) of the error-related-negativity (ERN\/Ne) and positivity (Pe)","volume":"20","author":"Herrmann","year":"2004","journal-title":"Cogn Brain Res"},{"key":"2019101113493814100_ref27","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1523\/JNEUROSCI.4052-11.2012","article-title":"Neurochemical enhancement of conscious error awareness","volume":"32","author":"Hester","year":"2012","journal-title":"J of Neurosci"},{"key":"2019101113493814100_ref28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1586\/ern.09.143","article-title":"Effect of second-generation antipsychotics on cognition: current issues and future challenges","volume":"10","author":"Hill","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"2019101113493814100_ref29","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1176\/ajp.156.9.1336","article-title":"Longitudinal neuropsychological follow-up study of patients with first-episode schizophrenia","volume":"156","author":"Hoff","year":"1999","journal-title":"Am J Psychiatry"},{"key":"2019101113493814100_ref30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0893-133X(01)00312-8","article-title":"Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum","volume":"26","author":"Ichikawa","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"2019101113493814100_ref31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1600-0447.1974.tb09707.x","article-title":"Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia","volume":"50","author":"Ingvar","year":"1974","journal-title":"Acta Psychiatr Scand"},{"key":"2019101113493814100_ref32","first-page":"371","article-title":"The ten-twenty electrode system of the International Federation","volume":"10","author":"Jasper","year":"1958","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"2019101113493814100_ref33","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.biopsych.2004.08.006","article-title":"Cortical effects of quetiapine in first-episode schizophrenia: a preliminary functional magnetic resonance imaging study","volume":"56","author":"Jones","year":"2004","journal-title":"Biol Psychiatry"},{"key":"2019101113493814100_ref34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0920-9964(03)80477-2","article-title":"Neurocognitive effects of olanzapine and low-dose haloperidol: a two-year treatment study in first episode psychosis","volume":"60","author":"Keefe","year":"2003","journal-title":"Schizophr Res"},{"key":"2019101113493814100_ref35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-642-25758-2_2","article-title":"Cognitive impairment in schizophrenia","volume-title":"Novel antischizophrenia treatments","author":"Keefe","year":"2012"},{"key":"2019101113493814100_ref36","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial","volume":"64","author":"Keefe","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"2019101113493814100_ref37","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1176\/appi.ajp.162.10.1833","article-title":"Decreased conflict- and error-related activity in the anterior cingulate cortex in subjects with schizophrenia","volume":"162","author":"Kerns","year":"2005","journal-title":"Am J Psychiatry"},{"key":"2019101113493814100_ref38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/1469-8986.3720216","article-title":"Error processing and the rostral anterior cingulate: an event-related fMRI study","volume":"37","author":"Kiehl","year":"2000","journal-title":"Psychophysiology"},{"key":"2019101113493814100_ref39","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1176\/appi.ajp.160.5.919","article-title":"Functional disconnection between the prefrontal and parietal cortices during working memory processing in schizophrenia: a[15(O)]H2O PET study","volume":"160","author":"Kim","year":"2003","journal-title":"Am J Psychiatry"},{"key":"2019101113493814100_ref40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1037\/0021-843X.108.2.337","article-title":"An event-related brain potential substrate of disturbed response monitoring in paranoid schizophrenic patients","volume":"108","author":"Kopp","year":"1999","journal-title":"J Abnorm Psychol"},{"key":"2019101113493814100_ref41","first-page":"38","article-title":"Flupenthixol\u2013a partial atypical neuroleptic? [Article in German]","volume":"68","author":"K\u00fchn","year":"2000","journal-title":"Fortschr Neurol Psychiatr"},{"key":"2019101113493814100_ref42","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/brain\/awg056","article-title":"Rostral anterior cingulate cortex dysfunction during error processing in schizophrenia","volume":"126","author":"Laurens","year":"2003","journal-title":"Brain"},{"key":"2019101113493814100_ref43","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1176\/appi.ajp.160.7.1209","article-title":"Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials","volume":"160","author":"Leucht","year":"2003","journal-title":"Am J Psychiatry"},{"key":"2019101113493814100_ref44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation vs. first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"The Lancet"},{"key":"2019101113493814100_ref45","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4088\/JCP.v68n0303","article-title":"A randomized controlled trial of olanzapine vs. haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia","volume":"68","author":"Lindenmayer","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"2019101113493814100_ref46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1037\/0021-843X.111.1.22","article-title":"Response-monitoring dysfunction in schizophrenia: an event-related brain potential study","volume":"111","author":"Mathalon","year":"2002","journal-title":"J Abnorm Psychol"},{"key":"2019101113493814100_ref47","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijpsycho.2009.02.005","article-title":"Error detection failures in schizophrenia: ERPs and FMRI","volume":"73","author":"Mathalon","year":"2009","journal-title":"Int J Psychophysiol"},{"key":"2019101113493814100_ref48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0920-9964(99)00198-X","article-title":"The role of cognition in vocational functioning in schizophrenia","volume":"45","author":"McGurk","year":"2000","journal-title":"Schizophr Res"},{"key":"2019101113493814100_ref49","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","article-title":"The role of serotonin receptors in the action of atypical antipsychotic drugs","volume":"11","author":"Meltzer","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"2019101113493814100_ref50","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/oxfordjournals.schbul.a033376","article-title":"the effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia","volume":"25","author":"Meltzer","year":"1999","journal-title":"Schizophr Bull"},{"key":"2019101113493814100_ref51","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/archpsyc.64.2.156","article-title":"Effects of \u03b3-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia","volume":"64","author":"Menzies","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"2019101113493814100_ref52","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00213-006-0446-8","article-title":"Dose effects of triazolam on brain activity during episodic memory encoding: a PET study","volume":"188","author":"Mintzer","year":"2006","journal-title":"Psychopharmacology"},{"key":"2019101113493814100_ref53","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.clinthera.2008.04.012","article-title":"The effects of atypical and conventional antipsychotics on reduced processing speed and psychomotor slowing in schizophrenia: a cross-sectional exploratory study","volume":"30","author":"Morrens","year":"2008","journal-title":"Clin Ther"},{"key":"2019101113493814100_ref54","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1037\/0021-843X.115.2.239","article-title":"Electrophysiological analysis of error monitoring in schizophrenia","volume":"115","author":"Morris","year":"2006","journal-title":"J Abnorm Psychol"},{"key":"2019101113493814100_ref55","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neures.2011.03.009","article-title":"Behavioural and neural effects of diazepam on a rule-guided response selection task","volume":"70","author":"Munoz-Torres","year":"2011","journal-title":"Neurosci Res"},{"key":"2019101113493814100_ref56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0920-9964(94)90006-X","article-title":"Stability of cognitive functioning early in the course of schizophrenia","volume":"14","author":"Nopoulos","year":"1994","journal-title":"Schizophr Res"},{"key":"2019101113493814100_ref57","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00213-009-1597-1","article-title":"Short-term antidepressant treatment modulates amygdala response to happy faces","volume":"206","author":"Norbury","year":"2009","journal-title":"Psychopharmacology"},{"key":"2019101113493814100_ref58","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1093\/schbul\/sbr084","article-title":"Neurocognitive predictors of work outcome in recent-onset schizophrenia","volume":"37","author":"Nuechterlein","year":"2011","journal-title":"Schizophr Bull"},{"key":"2019101113493814100_ref59","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/j.1469-8986.2009.00848.x","article-title":"The stability of error-related brain activity with increasing trials","volume":"46","author":"Olvet","year":"2009","journal-title":"Psychophysiology"},{"key":"2019101113493814100_ref60","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/FTD.0b013e3182708ec5.","article-title":"Therapeutic drug monitoring of common antipsychotics","volume":"34","author":"Patteet","year":"2012","journal-title":"Ther Drug Monit"},{"key":"2019101113493814100_ref61","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/35077500","article-title":"Primate anterior cingulate cortex: where motor control, drive and cognition interface","volume":"2","author":"Paus","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"2019101113493814100_ref62","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.clinthera.2005.07.015","article-title":"Treatment of cognitive dysfunction in schizophrenia","volume":"27","author":"Peuskens","year":"2005","journal-title":"Clin Ther"},{"key":"2019101113493814100_ref63","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/brain\/awm307","article-title":"Reduced error-related activation in two anterior cingulate circuits is related to impaired performance in schizophrenia","volume":"131","author":"Polli","year":"2008","journal-title":"Brain"},{"key":"2019101113493814100_ref64","first-page":"767","article-title":"On the number of trials necessary for stabilization of error-related brain activity across the life span","volume":"47","author":"Pontifex","year":"2010","journal-title":"Psychophysiology"},{"key":"2019101113493814100_ref65","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s00406-007-0748-9","article-title":"Efficacy of olanzapine vs. quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia","volume":"257","author":"Riedel","year":"2007","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2019101113493814100_ref66","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00406-007-0739-x","article-title":"Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms","volume":"257","author":"Riedel","year":"2007","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2019101113493814100_ref67","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1001\/jama.290.20.2693","article-title":"Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial","volume":"290","author":"Rosenheck","year":"2003","journal-title":"J Am Med Assoc"},{"key":"2019101113493814100_ref68","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4088\/JCP.10m06584","article-title":"Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study","volume":"73","author":"Ruh\u00e9","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"2019101113493814100_ref69","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1742-7843.2007.00017.x","article-title":"Metabolic drug interactions with newer antipsychotics: a comparative review","volume":"100","author":"Spina","year":"2007","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2019101113493814100_ref70","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pnpbp.2004.08.015","article-title":"Restoration of frontal activation during a treatment with quetiapine: an fMRI study of blunted affect in schizophrenia","volume":"29","author":"Stip","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2019101113493814100_ref71","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/15622970902898980","article-title":"Schizophrenia: from the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markers","volume":"10","author":"Stoeber","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"2019101113493814100_ref72","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/0269881113478281","article-title":"Comparison of the anti-dopamine D2 and anti-serotonin 5-HT2A activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof","volume":"27","author":"Suzuki","year":"2013","journal-title":"J Psychopharmacol"},{"key":"2019101113493814100_ref73","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0920-9964(99)00155-3","article-title":"Reduced anterior cingulate gyrus volume correlates with executive dysfunction in men with first-episode schizophrenia","volume":"43","author":"Szeszko","year":"2000","journal-title":"Schizophr Res"},{"key":"2019101113493814100_ref74","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/0269881105057002","article-title":"The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review","volume":"20","author":"Thornton","year":"2006","journal-title":"J Psychopharmacol"},{"key":"2019101113493814100_ref75","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.schres.2004.08.018","article-title":"A cross-study meta-analysis and three-dimensional comparison of cell counting in the anterior cingulate cortex of schizophrenic and bipolar brain","volume":"73","author":"Todtenkopf","year":"2005","journal-title":"Schizophr Res"},{"key":"2019101113493814100_ref76","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0031-9384(02)00930-7","article-title":"The anterior cingulate as a conflict monitor: fMRI and ERP studies","volume":"77","author":"van Veen","year":"2002","journal-title":"Physiol Behav"},{"key":"2019101113493814100_ref77","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0301-0511(03)00097-8","article-title":"Error negativity on correct trials: a reexamination of available data","volume":"64","author":"Vidal","year":"2003","journal-title":"Biol Psychol"},{"key":"2019101113493814100_ref78","volume-title":"Strukturiertes klinisches interview f\u00fcr DSM-IV","author":"Wittchen","year":"1997"},{"key":"2019101113493814100_ref79","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J Clin Psych"},{"key":"2019101113493814100_ref80","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1017\/S146114570500516X","article-title":"A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia","volume":"8","author":"Woodward","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"2019101113493814100_ref81","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00702-004-0230-z","article-title":"Reduced prefrontal response control in patients with schizophrenias: a subgroup analysis","volume":"112","author":"Zielasek","year":"2005","journal-title":"J Neural Transm"}],"container-title":["International Journal of Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/16\/9\/1911\/30135604\/16-9-1911.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijnp\/article-pdf\/16\/9\/1911\/30135604\/16-9-1911.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T10:19:00Z","timestamp":1688293140000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijnp\/article\/16\/9\/1911\/795361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,1]]},"references-count":81,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,10,1]]}},"URL":"https:\/\/doi.org\/10.1017\/s1461145713000540","relation":{},"ISSN":["1469-5111","1461-1457"],"issn-type":[{"value":"1469-5111","type":"electronic"},{"value":"1461-1457","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,10]]},"published":{"date-parts":[[2013,10,1]]}}}